NPS Pharmaceuticals (NPSP) 24.55 $NPSP
NPS Pharmaceuticals Falls 1.43% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 14, 5:35PM CDT
NPS Pharmaceuticals (NASDAQ:NPSP) traded in a range yesterday that spanned from a low of $22.90 to a high of $25.04. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $23.51 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Shares of NPSP Down 25.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 11, 10:04AM CDT
SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 1 month, NPS Pharmaceuticals has returned 25.40% as of today's recent price of $24.78.
Critical Alerts For 3D Systems, Activision, AIG, YPF S.A., and NPS Pharmaceuticals Released By InvestorsObserver
PR Newswire - Wed Apr 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DDD, ATVI, AIG, YPF, and NPSP.
Downtrend Call Working As NPS Pharmaceuticals Stock Falls 17.0% (NPSP)
Comtex SmarTrend(R) - Fri Apr 04, 9:28AM CDT
SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 4 weeks, NPS Pharmaceuticals has returned 16.97% as of today's recent price of $27.58.
NPS Pharmaceuticals to Present at Needham Healthcare Conference
Business Wire - Mon Mar 31, 3:10PM CDT
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 13th Annual Needham Healthcare Conference in New York on Tuesday, April 8, 2014 at 8:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the investors' calendar of events page on the NPS website at http://www.npsp.com/calendar.
Top Gainers Technical Data -- Research on NPS Pharma., HD Supply Holdings, Sonic, and McCormick & Co.
PR Newswire - Wed Mar 26, 10:24AM CDT
The US markets saw a positive sentiment on Tuesday, March 25, 2014, with the NASDAQ Composite closing at 4,234.27, up 0.19%, the Dow Jones Industrial Average ending the session at 16,367.88, up 0.56% and the S&P 500 edging 0.44% higher to finish the trading session at 1,865.62. The gains were broad based as nine out of 10 sectors ended the session in positive. A number of stocks saw large movements, including NPS Pharmaceuticals Inc. (NASDAQ: NPSP), HD Supply Holdings Inc. (NASDAQ: HDS), Sonic Corp. (NASDAQ: SONC) and McCormick & Co. Inc. (NYSE: MKC). Free technical research on NPSP, HDS, SONC and MKC can be downloaded upon signing up at:
NPS Pharmaceuticals Shares Down 10.9% Since SmarTrend's Sell Call (NPSP)
Comtex SmarTrend(R) - Tue Mar 25, 9:26AM CDT
SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 3 weeks, NPS Pharmaceuticals has returned 10.91% as of today's recent price of $29.59.
Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's "Dead Cat Bounce" Stock
at The Street - Tue Mar 25, 8:45AM CDT
Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "dead cat bounce" (down big yesterday but up big today) candidate
NPS Pharmaceuticals Expands Executive Leadership Team to Support its U.S. and International Growth and Global Orphan-Drug Leadership
Business Wire - Tue Mar 25, 7:10AM CDT
-- Eric Pauwels promoted to President, NPS Pharma International --
Earnings Look Back: NPS Pharmaceuticals Is Down 12.6% Since Reporting Quarterly Results 2 Weeks Ago (NPSP)
Comtex SmarTrend(R) - Mon Mar 10, 7:48AM CDT
Two weeks ago on February 18th, 2014 NPS Pharmaceuticals (NASDAQ:NPSP) reported earnings and analysts, on average, expected earnings of $0.03 on sales of $45.2 million. The company actually reported EPS of $0.07 on sales of $54.5 million, beating EPS estimates by $0.05 and beating revenue estimates by $9.3 million. Shares of NPS Pharmaceuticals have slipped from $37.95 to $33.18, representing a loss of 12.6%, since the company reported earnings 20 days ago.
Stem Cell Therapeutics Strengthens its Board of Directors
Marketwire - Mon Mar 10, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that Mr. Luke Beshar and Dr. Thomas Reynolds have been appointed to the Company's Board of Directors.
Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals
PR Newswire - Wed Mar 05, 12:08PM CST
Editor Note: For more information about this release, please scroll to bottom.
NPS Pharmaceuticals Has Returned 30.2% Since SmarTrend Recommendation (NPSP)
Comtex SmarTrend(R) - Wed Mar 05, 11:08AM CST
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 3 months, NPS Pharmaceuticals has returned 30.24% as of today's recent price of $35.21.
NPS Pharmaceuticals Joins Participants from around the World in Observing Rare Disease Day
Business Wire - Fri Feb 28, 7:30AM CST
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today joins patient organizations, healthcare professionals, researchers, public health authorities and the biopharmaceutical industry in recognizing Rare Disease Day. As a "Friend of Rare Disease Day," NPS strives to increase recognition of rare diseases and educate the public about their global impact on society. Internationally, the observance is led by the European Organisation for Rare Diseases (EURORDIS) and in the US by the National Organization for Rare Disorders (NORD).
NPS Pharmaceuticals to Present at Barclays Global Healthcare Conference
Business Wire - Wed Feb 26, 3:10PM CST
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Barclays Global Healthcare Conference in Miami, Florida on Tuesday, March 11, 2014 at 9:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the investors' calendar of events page on the NPS website at http://www.npsp.com/calendar.
Look for Shares of NPS Pharmaceuticals to Potentially Rebound after Yesterday's 4.22% Sell Off
Comtex SmarTrend(R) - Wed Feb 19, 5:39PM CST
NPS Pharmaceuticals (NASDAQ:NPSP) traded in a range yesterday that spanned from a low of $36.00 to a high of $37.94. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $36.94 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why NPS Pharmaceuticals, Inc. Shares Slipped
Brian Pacampara, The Motley Fool - Motley Fool - Wed Feb 19, 1:21PM CST
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking upgrades and downgrades -- just in case their reasoning behind the call makes sense. ...
37.0% Return Seen to Date on SmarTrend NPS Pharmaceuticals Call (NPSP)
Comtex SmarTrend(R) - Wed Feb 19, 9:12AM CST
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 2 months, NPS Pharmaceuticals has returned 36.97% as of today's recent price of $37.03.
NPS Pharmaceuticals Falls 1.43% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 14, 5:35PM CDT
NPS Pharmaceuticals (NASDAQ:NPSP) traded in a range yesterday that spanned from a low of $22.90 to a high of $25.04. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $23.51 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Shares of NPSP Down 25.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 11, 10:04AM CDT
SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 1 month, NPS Pharmaceuticals has returned 25.40% as of today's recent price of $24.78.
Critical Alerts For 3D Systems, Activision, AIG, YPF S.A., and NPS Pharmaceuticals Released By InvestorsObserver
PR Newswire - Wed Apr 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DDD, ATVI, AIG, YPF, and NPSP.
Downtrend Call Working As NPS Pharmaceuticals Stock Falls 17.0% (NPSP)
Comtex SmarTrend(R) - Fri Apr 04, 9:28AM CDT
SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 4 weeks, NPS Pharmaceuticals has returned 16.97% as of today's recent price of $27.58.
NPS Pharmaceuticals to Present at Needham Healthcare Conference
Business Wire - Mon Mar 31, 3:10PM CDT
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 13th Annual Needham Healthcare Conference in New York on Tuesday, April 8, 2014 at 8:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the investors' calendar of events page on the NPS website at http://www.npsp.com/calendar.
Top Gainers Technical Data -- Research on NPS Pharma., HD Supply Holdings, Sonic, and McCormick & Co.
PR Newswire - Wed Mar 26, 10:24AM CDT
The US markets saw a positive sentiment on Tuesday, March 25, 2014, with the NASDAQ Composite closing at 4,234.27, up 0.19%, the Dow Jones Industrial Average ending the session at 16,367.88, up 0.56% and the S&P 500 edging 0.44% higher to finish the trading session at 1,865.62. The gains were broad based as nine out of 10 sectors ended the session in positive. A number of stocks saw large movements, including NPS Pharmaceuticals Inc. (NASDAQ: NPSP), HD Supply Holdings Inc. (NASDAQ: HDS), Sonic Corp. (NASDAQ: SONC) and McCormick & Co. Inc. (NYSE: MKC). Free technical research on NPSP, HDS, SONC and MKC can be downloaded upon signing up at:
NPS Pharmaceuticals Shares Down 10.9% Since SmarTrend's Sell Call (NPSP)
Comtex SmarTrend(R) - Tue Mar 25, 9:26AM CDT
SmarTrend identified a Downtrend for NPS Pharmaceuticals (NASDAQ:NPSP) on March 6th, 2014 at $33.22. In approximately 3 weeks, NPS Pharmaceuticals has returned 10.91% as of today's recent price of $29.59.
Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's "Dead Cat Bounce" Stock
at The Street - Tue Mar 25, 8:45AM CDT
Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "dead cat bounce" (down big yesterday but up big today) candidate
NPS Pharmaceuticals Expands Executive Leadership Team to Support its U.S. and International Growth and Global Orphan-Drug Leadership
Business Wire - Tue Mar 25, 7:10AM CDT
-- Eric Pauwels promoted to President, NPS Pharma International --
Earnings Look Back: NPS Pharmaceuticals Is Down 12.6% Since Reporting Quarterly Results 2 Weeks Ago (NPSP)
Comtex SmarTrend(R) - Mon Mar 10, 7:48AM CDT
Two weeks ago on February 18th, 2014 NPS Pharmaceuticals (NASDAQ:NPSP) reported earnings and analysts, on average, expected earnings of $0.03 on sales of $45.2 million. The company actually reported EPS of $0.07 on sales of $54.5 million, beating EPS estimates by $0.05 and beating revenue estimates by $9.3 million. Shares of NPS Pharmaceuticals have slipped from $37.95 to $33.18, representing a loss of 12.6%, since the company reported earnings 20 days ago.
Stem Cell Therapeutics Strengthens its Board of Directors
Marketwire - Mon Mar 10, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that Mr. Luke Beshar and Dr. Thomas Reynolds have been appointed to the Company's Board of Directors.
Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals
PR Newswire - Wed Mar 05, 12:08PM CST
Editor Note: For more information about this release, please scroll to bottom.
NPS Pharmaceuticals Has Returned 30.2% Since SmarTrend Recommendation (NPSP)
Comtex SmarTrend(R) - Wed Mar 05, 11:08AM CST
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 3 months, NPS Pharmaceuticals has returned 30.24% as of today's recent price of $35.21.
NPS Pharmaceuticals Joins Participants from around the World in Observing Rare Disease Day
Business Wire - Fri Feb 28, 7:30AM CST
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today joins patient organizations, healthcare professionals, researchers, public health authorities and the biopharmaceutical industry in recognizing Rare Disease Day. As a "Friend of Rare Disease Day," NPS strives to increase recognition of rare diseases and educate the public about their global impact on society. Internationally, the observance is led by the European Organisation for Rare Diseases (EURORDIS) and in the US by the National Organization for Rare Disorders (NORD).
NPS Pharmaceuticals to Present at Barclays Global Healthcare Conference
Business Wire - Wed Feb 26, 3:10PM CST
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Barclays Global Healthcare Conference in Miami, Florida on Tuesday, March 11, 2014 at 9:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the investors' calendar of events page on the NPS website at http://www.npsp.com/calendar.
Look for Shares of NPS Pharmaceuticals to Potentially Rebound after Yesterday's 4.22% Sell Off
Comtex SmarTrend(R) - Wed Feb 19, 5:39PM CST
NPS Pharmaceuticals (NASDAQ:NPSP) traded in a range yesterday that spanned from a low of $36.00 to a high of $37.94. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $36.94 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why NPS Pharmaceuticals, Inc. Shares Slipped
Brian Pacampara, The Motley Fool - Motley Fool - Wed Feb 19, 1:21PM CST
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking upgrades and downgrades -- just in case their reasoning behind the call makes sense. ...
37.0% Return Seen to Date on SmarTrend NPS Pharmaceuticals Call (NPSP)
Comtex SmarTrend(R) - Wed Feb 19, 9:12AM CST
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on December 19th, 2013 at $27.04. In approximately 2 months, NPS Pharmaceuticals has returned 36.97% as of today's recent price of $37.03.
